About IXICO
IXICO has been working since 2004 to help advance therapies for neurological diseases
Background
IXICO is dedicated to delivering insights in neuroscience. Our mission is to transform the advancement of investigational therapies for neurological diseases through the application of medical image analysis and digital health data analytics, bringing safe and effective treatment to patients sooner.
We deliver specialist data analytics services that identify and measure unique biomarkers from brain scan and wearable biosensor data produced in clinical research programmes. The results we deliver support our clients in their clinical decisions to align patient selection, protect patient safety and assess disease progression and drug efficacy.
Our neuroimaging and digital biomarkers are powering some of the most important clinical trials in neuroscience today. IXICO is also collaborating with partners and developing new analytical techniques and companion digital health products to impact patient outcomes.
IXICO's timeline
2004
IXICO founded
A spin-out from London universities' ‘Information eXtraction from Images’ project.
2006
Clinical trial platform launched
IXICO provides neuroscience expertise and global operations to deliver imaging and digital biomarker analytical services for clinical development, within a framework of regulatory compliance.
2007
First Phase 3 trial
IXICO is awarded it's first Phase 3 study for Alzheimer's disease.
2008
Web-based TrialTracker platform launched
The TrialTrackerTM data managment platform is a secure and compliant environment for the collection, analysis and interpretation of large image files and other data that may be generated in the course of a clinical study.
2013
AIM listing
IXICO was listed on the Alternative Investment Market (AIM), a sub-market of the London Stock Exchange (LSE).
2014
Assessa platform launched
The clinical decision support platform, Assessa provides access to expert neuroradiologists for a standardized radiological read, and securely captures then transfers clinical data and MR images from referring neurologists to expert neuroradiologists.
2015
Post-marketing surveillance commercial collaboration
IXICO are partnering with pharma companies to develop digital clinical decision support technologies based on our Assessa platform technology to improve the targeting and the safety and effectiveness of their therapeutics.
2017
Digital biomarkers commercial collaboration
The arrival of connected digital technologies (wearable biosensors and mobile devices) that enable the passive measurement of parameters such as sleep, activity and heart rate outside of the clinic, has provided the opportunity to revolutionize the capture of data in clinical trials.
2018
Product Investment
Oversubscribed placing of £5.5m to invest in new product and new market development
2019
King's College Partnership
IXICO was chosen as partner for King's College London's UK Government-funded Medical Imaging & Artificial Intelligence Centre
Public & Private Partnerships
Innovation is one of our core values, and collaboration is key to advancing treatments for neurological diseases. Working with partners in academia, business and charitable organisations, we help further the international scientific and regulatory agenda and provide access to our platform and advanced data analysis for innovative research.
Work with us
Careers at IXICO
IXICO is a fast-growing data analytics company based in London, UK, working with biopharmaceutical clients, academic partners and clinical research sites around the world.
Specializing in supporting clinical research in neuroscience, we are a passionate and dedicated team of scientists, researchers, quality professionals, and business people, bringing together the essential skills required to innovate and develop and deliver cutting-edge technologies to support our clients' clinical research needs.